{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T19:53:09Z","timestamp":1775937189224,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:00:00Z","timestamp":1551744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T00:00:00Z","timestamp":1551744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1208\/s12249-019-1346-7","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T16:07:23Z","timestamp":1551802043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Antifungal and Mucoadhesive Properties of an Orally Administered Chitosan-Coated Amphotericin B Nanostructured Lipid Carrier (NLC)"],"prefix":"10.1208","volume":"20","author":[{"given":"Janet Tan Sui","family":"Ling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8496-1882","authenticated-orcid":false,"given":"Nashiru","family":"Billa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,5]]},"reference":[{"key":"1346_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00253-005-1955-9","volume":"68","author":"A Lemke","year":"2005","unstructured":"Lemke A, Kiderlen AF, Kayser O. Amphotericin B. Appl Microbiol Biotechnol. 2005;68:151\u201362.","journal-title":"Appl Microbiol Biotechnol"},{"key":"1346_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijpharm.2009.01.003","volume":"372","author":"EK Wasan","year":"2009","unstructured":"Wasan EK, Bartlett K, Gershkovich P, Sivak O, Banno B, Wong Z, et al. Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans. Int J Pharm. 2009;372:76\u201384.","journal-title":"Int J Pharm"},{"key":"1346_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.rvsc.2017.12.005","volume":"117","author":"J Nieto","year":"2018","unstructured":"Nieto J, Alvar J, Rodr\u00edguez C, San Andr\u00e9s MI, San Andr\u00e9s MD, Gonz\u00e1lez F. Comparison of conventional and lipid emulsion formulations of amphotericin B: pharmacokinetics and toxicokinetics in dogs. Res Vet Sci. 2018;117:125\u201332.","journal-title":"Res Vet Sci"},{"key":"1346_CR4","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1128\/AAC.36.10.2310","volume":"36","author":"J Barwicz","year":"1992","unstructured":"Barwicz J, Christian S, Gruda I. Effects of the aggregation state of amphotericin B on its toxicity to mice. Antimicrob Agents Chemother. 1992;36:2310\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"1346_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.colsurfb.2015.07.032","volume":"139","author":"D Butani","year":"2016","unstructured":"Butani D, Yewale C, Misra A. Topical amphotericin B solid lipid nanoparticles: design and development. Colloids Surf B Biointerfaces. 2016;139:17\u201324.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1346_CR6","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1128\/AAC.44.9.2356-2360.2000","volume":"44","author":"R Santangelo","year":"2000","unstructured":"Santangelo R, Paderu P, Delmas G, Chen ZW, Mannino R, Zarif L, et al. Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis. Antimicrob Agents Chemother. 2000;44:2356\u201360.","journal-title":"Antimicrob Agents Chemother"},{"key":"1346_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.nano.2008.03.007","volume":"4","author":"M Nahar","year":"2008","unstructured":"Nahar M, Mishra D, Dubey V, Jain NK. Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomedicine. 2008;4:252\u201361.","journal-title":"Nanomedicine"},{"key":"1346_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.colsurfa.2010.09.030","volume":"372","author":"SW Tan","year":"2010","unstructured":"Tan SW, Billa N, Roberts CR, Burley JC. Surfactant effects on the physical characteristics of amphotericin B-containing nanostructured lipid carriers. Colloids Surf A Physicochem Eng Asp. 2010;372:73\u20139.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"1346_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1208\/s12249-014-0279-4","volume":"16","author":"H Amekyeh","year":"2015","unstructured":"Amekyeh H, Billa N, Yuen K-H, Chin SLS. A gastrointestinal transit study on amphotericin B-loaded solid lipid nanoparticles in rats. AAPS PharmSciTech. 2015;16:871\u20137.","journal-title":"AAPS PharmSciTech"},{"key":"1346_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jddst.2017.10.013","volume":"43","author":"R Vaghela","year":"2018","unstructured":"Vaghela R, Kulkarni PK, Osmani RAM, Naga Sravan Kumar Varma V, Bhosale RR, Raizaday A, et al. Design, development and evaluation of mannosylated oral amphotericin B nanoparticles for anti-leishmanial therapy: oral kinetics and macrophage uptake studies. J Drug Deliv Sci Technol. 2018;43:283\u201394.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1346_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jddst.2018.05.001","volume":"46","author":"ZA Ishaq","year":"2018","unstructured":"Ishaq ZA, Ahmed N, Anwar MN, ul-Haq I, ur-Rehman T, Ahmad NM, et al. Development and in vitro evaluation of cost effective amphotericin B polymeric emulsion. J Drug Deliv Sci Technol. 2018;46:66\u201373.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1346_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.carbpol.2018.04.013","volume":"194","author":"T Jabri","year":"2018","unstructured":"Jabri T, Imran M, Shafiullah RK, Ali I, Arfan M, Shah MR. Fabrication of lecithin-gum tragacanth muco-adhesive hybrid nano-carrier system for in-vivo performance of amphotericin B. Carbohydr Polym. 2018;194:89\u201396.","journal-title":"Carbohydr Polym"},{"key":"1346_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.05.013","volume":"361","author":"R Espada","year":"2008","unstructured":"Espada R, Valdespina S, Alfonso C, Rivas G, Ballesteros MP, Torrado JJ. Effect of aggregation state on the toxicity of different amphotericin B preparations. Int J Pharm. 2008;361:64\u20139.","journal-title":"Int J Pharm"},{"key":"1346_CR14","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","volume":"73","author":"RJ Hamill","year":"2013","unstructured":"Hamill RJ. Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs. 2013;73:919\u201334.","journal-title":"Drugs."},{"key":"1346_CR15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ijpharm.2013.05.044","volume":"454","author":"AE Silva","year":"2013","unstructured":"Silva AE, Barratt G, Che\u0155on M, Egito EST. Development of oil-in-water microemulsions for the oral delivery of amphotericin B. Int J Pharm. 2013;454:641\u20138.","journal-title":"Int J Pharm"},{"key":"1346_CR16","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1080\/03639040802130061","volume":"34","author":"M Muchow","year":"2008","unstructured":"Muchow M, Maincent P, Muller RH. Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery. Drug Dev Ind Pharm. 2008;34:1394\u2013405.","journal-title":"Drug Dev Ind Pharm"},{"key":"1346_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s40005-013-0087-y","volume":"43","author":"G Yoon","year":"2013","unstructured":"Yoon G, Park JW, Yoon I. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery. J Pharm Investig. 2013;43:353\u201362.","journal-title":"J Pharm Investig"},{"key":"1346_CR18","doi-asserted-by":"crossref","unstructured":"Tan Sui Ling J, Billa N, Roberts CJ. Mucoadhesive chitosan-coated nanostructured lipid carriers for oral delivery of amphotericin B. Pharm Dev Technol. 2018:1\u201324.","DOI":"10.1080\/10837450.2018.1515225"},{"key":"1346_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","volume":"133","author":"A Gordillo-galeano","year":"2018","unstructured":"Gordillo-galeano A, Mora-huertas CE. Solid lipid nanoparticles and nanostructured lipid carriers : a review emphasizing on particle structure and drug release. Eur J Pharm Biopharm. 2018;133:285\u2013308.","journal-title":"Eur J Pharm Biopharm"},{"key":"1346_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/08982104.2016.1224899","volume":"27","author":"T Fu","year":"2016","unstructured":"Fu T, Yi J, Lv S, Zhang B. Ocular amphotericin B delivery by chitosan modified nanostructured lipid carriers for fungal keratitis targeted therapy. J Liposome Res. 2016;27:228\u201333.","journal-title":"J Liposome Res"},{"key":"1346_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1166\/jbt.2014.1136","volume":"4","author":"P Tripathi","year":"2014","unstructured":"Tripathi P, Verma A, Dwivedi P, Sharma D, Kumar V. Formulation and characterization of amphotericin B loaded nanostructured lipid carriers using microfluidizer. J Biomimetics Biomater Tissue Eng. 2014;4:1\u20134.","journal-title":"J Biomimetics Biomater Tissue Eng"},{"key":"1346_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijpharm.2010.10.013","volume":"403","author":"Q Luo","year":"2011","unstructured":"Luo Q, Zhao J, Zhang X, Pan W. Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm. 2011;403:185\u201391.","journal-title":"Int J Pharm"},{"key":"1346_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.carbpol.2014.12.084","volume":"122","author":"Y Luo","year":"2015","unstructured":"Luo Y, Teng Z, Li Y, Wang Q. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. Carbohydr Polym. 2015;122:221\u20139.","journal-title":"Carbohydr Polym"},{"key":"1346_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jddst.2017.10.025","volume":"43","author":"A Deb","year":"2018","unstructured":"Deb A, Vimala R. Camptothecin loaded graphene oxide nanoparticle functionalized with polyethylene glycol and folic acid for anticancer drug delivery. J Drug Deliv Sci Technol. 2018;43:333\u201342.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1346_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejpb.2016.10.010","volume":"110","author":"G Sandri","year":"2017","unstructured":"Sandri G, Motta S, Bonferoni MC, Brocca P, Rossi S, Ferrari F, et al. Chitosan-coupled solid lipid nanoparticles: tuning nanostructure and mucoadhesion. Eur J Pharm Biopharm. 2017;110:13\u20138.","journal-title":"Eur J Pharm Biopharm"},{"key":"1346_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/B978-0-12-391860-4.00015-X","volume":"508","author":"P Fonte","year":"2012","unstructured":"Fonte P, Andrade F, Ara\u00fajo F, Andrade C, Das NJ, Sarmento B. Chitosan-coated solid lipid nanoparticles for insulin delivery. Methods Enzymol. 2012;508:295\u2013314.","journal-title":"Methods Enzymol"},{"key":"1346_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2014.02.005","volume":"87","author":"S Doktorovova","year":"2014","unstructured":"Doktorovova S, Souto EB, Silva AM. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data. Eur J Pharm Biopharm. 2014;87:1\u201318.","journal-title":"Eur J Pharm Biopharm"},{"key":"1346_CR28","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ejpb.2016.04.006","volume":"108","author":"I Garcia-Orue","year":"2016","unstructured":"Garcia-Orue I, Gainza G, Girbau C, Alonso R, Aguirre JJ, Pedraz JL, et al. LL37 loaded nanostructured lipid carriers (NLC): a new strategy for the topical treatment of chronic wounds. Eur J Pharm Biopharm. 2016;108:310\u20136.","journal-title":"Eur J Pharm Biopharm"},{"key":"1346_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijbiomac.2016.12.090","volume":"97","author":"MA Khan","year":"2017","unstructured":"Khan MA, Zafaryab M, Mehdi SH, Quadri J, Rizvi MMA. Characterization and carboplatin loaded chitosan nanoparticles for the chemotherapy against breast cancer in vitro studies. Int J Biol Macromol. 2017;97:115\u201322.","journal-title":"Int J Biol Macromol"},{"key":"1346_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1773-2247(10)50073-X","volume":"20","author":"MC Bonferoni","year":"2010","unstructured":"Bonferoni MC, Sandri G, Ferrari F, Rossi S, Larghi V, Zambito Y, et al. Comparison of different in vitro and ex vivo methods to evaluate mucoadhesion of glycol-palmitoyl chitosan micelles. J Drug Deliv Sci Technol. 2010;20:419\u201324.","journal-title":"J Drug Deliv Sci Technol."},{"key":"1346_CR31","first-page":"1","volume":"18","author":"E Alkhader","year":"2016","unstructured":"Alkhader E, Billa N, Roberts CJ. Mucoadhesive chitosan-pectinate nanoparticles for the delivery of curcumin to the colon. AAPS PharmSciTech. 2016;18:1\u201310.","journal-title":"AAPS PharmSciTech"},{"key":"1346_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ejps.2009.02.021","volume":"37","author":"SH Jung","year":"2009","unstructured":"Jung SH, Lim DH, Jung SH, Lee JE, Jeong K-S, Seong H, et al. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics. Eur J Pharm Sci. 2009;37:313\u201320.","journal-title":"Eur J Pharm Sci"},{"key":"1346_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/10717544.2016.1228715","volume":"24","author":"MA Radwan","year":"2017","unstructured":"Radwan MA, AlQuadeib BT, \u0160iller L, Wright MC, Horrocks B. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats. Drug Deliv. 2017;24:40\u201350.","journal-title":"Drug Deliv"},{"key":"1346_CR34","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ijpharm.2017.11.071","volume":"536","author":"ACC Vieira","year":"2018","unstructured":"Vieira ACC, Chaves LL, Pinheiro S, Pinto S, Pinheiro M, Lima SC, et al. Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis. Int J Pharm. 2018;536:478\u201385.","journal-title":"Int J Pharm"},{"key":"1346_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.lwt.2014.04.058","volume":"59","author":"NP Aditya","year":"2014","unstructured":"Aditya NP, Macedo AS, Doktorovova S, Souto EB, Kim S, Chang PS, et al. Development and evaluation of lipid nanocarriers for quercetin delivery: a comparative study of solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid nanoemulsions (LNE). LWT - Food Sci Technol. 2014;59:115\u201321.","journal-title":"LWT - Food Sci Technol"},{"key":"1346_CR36","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","volume":"58","author":"W Abdelwahed","year":"2006","unstructured":"Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58:1688\u2013713.","journal-title":"Adv Drug Deliv Rev"},{"key":"1346_CR37","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1002\/smll.201001199","volume":"6","author":"V Kumar","year":"2010","unstructured":"Kumar V, Adamson DH, Prud\u2019homme RK. Fluorescent polymeric nanoparticles: aggregation and phase behavior of pyrene and amphotericin B molecules in nanoparticle cores. Small. 2010;6:2907\u201314.","journal-title":"Small."},{"key":"1346_CR38","doi-asserted-by":"publisher","first-page":"31192","DOI":"10.1074\/jbc.M303938200","volume":"278","author":"G Drin","year":"2003","unstructured":"Drin G, Cottin S, Blanc E, Rees AR, Temsamani J. Studies on the internalization mechanism of cationic cell-penetrating peptides. J Biol Chem. 2003;278:31192\u2013201.","journal-title":"J Biol Chem"},{"key":"1346_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.colsurfb.2015.06.054","volume":"134","author":"O Gartziandia","year":"2015","unstructured":"Gartziandia O, Herran E, Pedraz JL, Carro E, Igartua M, Hernandez RM. Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration. Colloids Surf B Biointerfaces. 2015;134:304\u201313.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1346_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ijpharm.2011.05.044","volume":"415","author":"R Tiwari","year":"2011","unstructured":"Tiwari R, Pathak K. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm. 2011;415:232\u201343.","journal-title":"Int J Pharm"},{"key":"1346_CR41","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","volume":"103","author":"A Khosa","year":"2018","unstructured":"Khosa A, Reddi S, Saha RN. Nanostructured lipid carriers for site-specific drug delivery. Biomed Pharmacother. 2018;103:598\u2013613.","journal-title":"Biomed Pharmacother"},{"key":"1346_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejpb.2013.08.013","volume":"86","author":"S Weber","year":"2014","unstructured":"Weber S, Zimmer A, Pardeike J. Solid lipid nanoparticles ( SLN ) and nanostructured lipid carriers (NLC) for pulmonary application : a review of the state of the art. Eur J Pharm Biopharm. 2014;86:7\u201322.","journal-title":"Eur J Pharm Biopharm"},{"key":"1346_CR43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ejmech.2015.03.022","volume":"95","author":"ACO Souza","year":"2015","unstructured":"Souza ACO, Nascimento AL, de Vasconcelos NM, Jer\u00f4nimo MS, Siqueira IM, R-Santos L, et al. Activity and in vivo tracking of amphotericin B loaded PLGA nanoparticles. Eur J Med Chem. 2015;95:267\u201376.","journal-title":"Eur J Med Chem"},{"key":"1346_CR44","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s12010-014-1084-y","volume":"174","author":"V Jain","year":"2014","unstructured":"Jain V, Gupta A, Pawar VK, Asthana S, Jaiswal AK, Dube A, et al. Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles. Appl Biochem Biotechnol. 2014;174:1309\u201330.","journal-title":"Appl Biochem Biotechnol"},{"key":"1346_CR45","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ijbiomac.2017.04.098","volume":"102","author":"S Das","year":"2017","unstructured":"Das S, Ghosh S, De AK, Bera T. Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis. Int J Biol Macromol. 2017;102:996\u20131008.","journal-title":"Int J Biol Macromol"},{"key":"1346_CR46","doi-asserted-by":"crossref","unstructured":"Cauchetier E, Deniau M, Fessi H, Astier A, Paul M. Atovaquone-loaded nanocapsules: influence of the nature of the polymer on their in vitro characteristics. 2003;250:273\u2013281.","DOI":"10.1016\/S0378-5173(02)00556-2"},{"key":"1346_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijpharm.2009.10.018","volume":"385","author":"CE Mora-Huertas","year":"2010","unstructured":"Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm. 2010;385:113\u201342.","journal-title":"Int J Pharm"},{"key":"1346_CR48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","volume":"235","author":"S Bhattacharjee","year":"2016","unstructured":"Bhattacharjee S. DLS and zeta potential \u2013 what they are and what they are not? J Control Release. 2016;235:337\u201351.","journal-title":"J Control Release"},{"key":"1346_CR49","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.cocis.2005.11.001","volume":"11","author":"R Bansil","year":"2006","unstructured":"Bansil R, Turner BS. Mucin structure, aggregation, physiological functions and biomedical applications. Curr Opin Colloid Interface Sci. 2006;11:164\u201370.","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"1346_CR50","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.carbpol.2011.01.037","volume":"84","author":"XY Ying","year":"2011","unstructured":"Ying XY, Cui D, Yu L, Du YZ. Solid lipid nanoparticles modified with chitosan oligosaccharides for the controlled release of doxorubicin. Carbohydr Polym. 2011;84:1357\u201364.","journal-title":"Carbohydr Polym"},{"key":"1346_CR51","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.colsurfb.2011.11.051","volume":"93","author":"DM Ridolfi","year":"2012","unstructured":"Ridolfi DM, Marcato PD, Justo GZ, Cordi L, Machado D, Dur\u00e1n N. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin. Colloids Surf B Biointerfaces. 2012;93:36\u201340.","journal-title":"Colloids Surf B Biointerfaces."},{"key":"1346_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ejps.2015.01.015","volume":"70","author":"LR Caldeira","year":"2015","unstructured":"Caldeira LR, Fernandes FR, Costa DF, Frezard F, Afonso LCC, Ferreira LAM. Nanoemulsions loaded with amphotericin B: a new approach for the treatment of leishmaniasis. Eur J Pharm Sci. 2015;70:125\u201331.","journal-title":"Eur J Pharm Sci"},{"key":"1346_CR53","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.colsurfb.2018.03.015","volume":"166","author":"JP Senna","year":"2018","unstructured":"Senna JP, Barradas TN, Cardoso S, Castiglione TC, Serpe MJ, Silva KG de H, et al. Dual alginate-lipid nanocarriers as oral delivery systems for amphotericin B. Colloids Surf B Biointerfaces. 2018;166:187\u201394.","journal-title":"Colloids Surf B Biointerfaces."},{"key":"1346_CR54","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.2042-7158.1998.tb03319.x","volume":"50","author":"M Sakai","year":"1998","unstructured":"Sakai M, Imai T, Ohtake H, Otagiri M. Cytotoxicity of absorption enhancers in caco-2 cell monolayers. J Pharm Pharmacol. 1998;50:1101\u20138.","journal-title":"J Pharm Pharmacol"},{"key":"1346_CR55","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s11095-009-9841-2","volume":"26","author":"JL Italia","year":"2009","unstructured":"Italia JL, Yahya MM, Singh D, Ravi Kumar MNV. Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone\u00ae. Pharm Res. 2009;26:1324\u201331.","journal-title":"Pharm Res"},{"key":"1346_CR56","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.colsurfb.2015.11.050","volume":"139","author":"P Ramalingam","year":"2016","unstructured":"Ramalingam P, Ko YT. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles. Colloids Surf B Biointerfaces. 2016;139:52\u201361.","journal-title":"Colloids Surf B Biointerfaces."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1346-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-019-1346-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-019-1346-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T05:03:46Z","timestamp":1650431026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-019-1346-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,5]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1346"],"URL":"https:\/\/doi.org\/10.1208\/s12249-019-1346-7","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,5]]},"assertion":[{"value":"16 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"136"}}